UniSuper Management’s Pfizer PFE Stock Holding History

UniSuper Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	624,923 +193,046	+45%	+$5.05M	0.08%	146
2026 Q1	$12.1M	Buy	431,877 +324	+0.1%	+$8.63K	0.08%	151
2025 Q4	$10.7M	Sell	431,553 -69,072	-14%	-$1.74M	0.06%	157
2025 Q3	$12.8M	Buy	500,625 +144,843	+41%	+$3.58M	0.08%	148
2025 Q2	$8.62M	Sell	355,782 -6,501	-2%	-$152K	0.06%	174
2025 Q1	$9.18M	Buy	362,283 +12,538	+4%	+$328K	0.07%	159
2024 Q4	$9.28M	Buy	349,745 +90,289	+35%	+$2.45M	0.07%	163
2024 Q3	$7.51M	Buy	259,456 +3,025	+1%	+$88.2K	0.06%	184
2024 Q2	$7.17M	Sell	256,431 -203,366	-44%	-$5.6M	0.06%	175
2024 Q1	$12.8M	Sell	459,797 -681,905	-60%	-$18.9M	0.12%	121
2023 Q4	$32.9M	Sell	1,141,702 -42,041	-4%	-$1.27M	0.36%	66
2023 Q3	$39.3M	Sell	1,183,743 -128,707	-10%	-$4.55M	0.48%	55
2023 Q2	$48.1M	Buy	+1,312,450	New	+$51.1M	0.55%	51

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UniSuper Management's PFE Position: Q2 2026 in Review

UniSuper Management increased its Pfizer (PFE) stake by 45% in Q2 2026, buying an estimated $5.05M and bringing the position to 624,923 shares worth $15M. The position accounts for 0.08% of the portfolio, ranked #146.

UniSuper Management first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $48.1M in Q2 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

UniSuper Management held 624,923 shares of Pfizer worth $15M as of Q2 2026.
UniSuper Management bought 193,046 Pfizer shares in Q2 2026, an estimated $5.05M.
Pfizer made up 0.08% of UniSuper Management's portfolio in Q2 2026, its #146 holding.
UniSuper Management first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
UniSuper Management's Pfizer position peaked at $48.1M in Q2 2023.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.